Feb 10, 2022
- Feb 9, 2023
Advances in Disease Management of Generalized Myasthenia Gravis by Reducing Levels of IgG Autoantibodies

Claim your credit

Already have an Account? Log In
Don’t have an account? Register Today

Login to take this course.

This course is available for logged in users only. Please login or register to take the course.

Related Courses

Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeuti...
Optimal Contemporary Management of Hypertrophic Cardiomyopathy: The Importance of Early Di...
Early, Optimal Management of CKD and Cardiorenal Disease to Prevent Disease Progression an...